{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:46:44Z","timestamp":1793400404139,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241347-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cancer and its care impose significant time commitments on patients and care partners. The oncology community has only recently conceptualized these commitments and the associated burden as the \u201ctime toxicity\u201d of cancer care. As the concept gains traction, there is a critical need to fundamentally understand the perspectives of multiple stakeholders on the time burdens of cancer care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241347-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore time-consuming aspects of cancer care that were perceived as burdensome, identify the individuals most affected by time burdens of cancer care, and evaluate the consequences of these time burdens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241347-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Participants in this qualitative analysis were recruited from a National Cancer Institute\u2013designated cancer center in Minnesota, where semistructured qualitative interviews were conducted from February 1 to October 31, 2023. Purposive and criterion sampling methods were used to recruit patients (adults with advanced stage gastrointestinal cancer receiving systemic cancer-directed treatment), care partners (patient-identified informal [unpaid] partners), and clinicians (physicians, physician assistants, nurse practitioners, nurses, social workers, and schedulers). Data were analyzed from February 2023 to February 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241347-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Thematic analysis was conducted with a hybrid (inductive and deductive methods) approach. Themes, subthemes, and illustrative quotations are presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241347-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Interviews included 47 participants (16 patients [8 aged \u226460 years; 12 women (75.0%)], 15 care partners [12 aged \u226460 years; 9 women (60.0%)], and 16 clinicians [11 women (68.7%)]). A total of 31 subthemes were identified that were grouped into 5 themes. Theme 1 captured time burdens due to health care outside the home (eg, travel, parking, and waiting time), while theme 2 identified the often invisible tasks performed at home (eg, handling insurance and medical bills, receiving formal home-based care). Theme 3 explored how care partners are affected alongside patients (eg, burdens extending to the wider network of family, friends, and community) and theme 4 represented the consequences of time burdens (eg, demoralization, seemingly short visits turned into all-day affairs). Finally, theme 5 referenced positive time spent in clinical interactions and hope for change (eg, patients value meaningful care, the \u201ctime toxicity\u201d label is a spark for change).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241347-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This qualitative analysis identifies key sources and effects of time toxicity, as well as the populations affected. The results of this study will guide the oncology community to map, measure, and address future time burdens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.47649","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:33:51Z","timestamp":1732707231000},"page":"e2447649","source":"Crossref","is-referenced-by-count":75,"title":["Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer Care"],"prefix":"10.1001","volume":"7","author":[{"given":"Arjun","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney V.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obafemi O.","family":"Ogunleye","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethiya","family":"Sekar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"George","sequence":"additional","affiliation":[{"name":"Paltown Development Foundation\/COLONTOWN, Crownsville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Breininger","sequence":"additional","affiliation":[{"name":"The Negative Space, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Anne","family":"Kyle","sequence":"additional","affiliation":[{"name":"Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Booth","sequence":"additional","affiliation":[{"name":"Division of Cancer Care and Epidemiology, Queen\u2019s Cancer Research Institute, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Hanna","sequence":"additional","affiliation":[{"name":"Division of Cancer Care and Epidemiology, Queen\u2019s Cancer Research Institute, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle B.","family":"Rocque","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Parsons","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel I.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Blaes","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"9","key":"zoi241347r1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1200\/OP.20.01071","article-title":"Maximizing home time for persons with cancer.","volume":"17","author":"Banerjee","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"15","key":"zoi241347r2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","article-title":"The time toxicity of cancer treatment.","volume":"40","author":"Gupta","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"zoi241347r3","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/oncolo\/oyad128","article-title":"Contact days associated with cancer treatments in the CCTG LY.12 trial.","volume":"28","author":"Gupta","year":"2023","journal-title":"Oncologist"},{"key":"zoi241347r4","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad313","article-title":"Trajectory of healthcare contact days for veterans with advanced gastrointestinal malignancy.","author":"Johnson","year":"2024","journal-title":"Oncologist"},{"issue":"11","key":"zoi241347r5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/OP.23.00232","article-title":"Health care contact days experienced by decedents with advanced GI cancer.","volume":"19","author":"Patel","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"zoi241347r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.4278","article-title":"Trajectories of health care contact days for patients with stage IV non\u2013small cell lung cancer.","volume":"7","author":"Gupta","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi241347r7","doi-asserted-by":"publisher","author":"Durbin","journal-title":"J Clin Oncol","DOI":"10.1200\/JCO.2022.40.28_suppl.236"},{"issue":"6","key":"zoi241347r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102046","article-title":"Time toxicity associated with early phase clinical trial participation.","volume":"8","author":"Nindra","year":"2023","journal-title":"ESMO Open"},{"issue":"6","key":"zoi241347r9","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1200\/OP.22.00737","article-title":"Evaluating the time toxicity of cancer treatment in the CCTG CO.17 trial.","volume":"19","author":"Gupta","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"zoi241347r10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/jnci\/djae077","article-title":"The association of health-care contact days with physical function and survival in CCTG\/AGITG CO.17.","volume":"116","author":"Gupta","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"zoi241347r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28452","article-title":"Accuracy of a text intervention to minimize the burden of cancer care among patients treated with immune checkpoint inhibitors.","volume":"5","author":"Bange","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi241347r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300852","article-title":"Logistic burdens of cancer care: a qualitative study.","volume":"19","author":"Dona","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"zoi241347r13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mayocpiqo.2023.09.003","article-title":"The faces of financial toxicity: a qualitative interview study of financial toxicity in advanced cancer patients in phase I oncology trials.","volume":"7","author":"Williams","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"3","key":"zoi241347r14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN.","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"zoi241347r15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jnma.2022.04.001","article-title":"Racial and ethnic disparities in incidence and mortality for the five most common gastrointestinal cancers in the United States.","volume":"114","author":"Bui","year":"2022","journal-title":"J Natl Med Assoc"},{"key":"zoi241347r16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.4003","author":"Dotan","year":"2024","journal-title":"J Clin Oncol"},{"issue":"5","key":"zoi241347r17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jgo.2022.02.003","article-title":"Estimated out-of-pocket costs for cancer-directed and supportive care medications for older adults with advanced pancreatic cancer.","volume":"13","author":"Desai","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"zoi241347r19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research.","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"issue":"6","key":"zoi241347r20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"zoi241347r21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286308","article-title":"Treatment burden in individuals living with and beyond cancer: a systematic review of qualitative literature.","volume":"18","author":"Adam","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"zoi241347r22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/146879410100100307","article-title":"Thematic networks: an analytic tool for qualitative research.","volume":"1","author":"Attride-Stirling","year":"2001","journal-title":"Qual Res"},{"key":"zoi241347r24","doi-asserted-by":"publisher","DOI":"10.1177\/160940690600500107","author":"Fereday","year":"2006","journal-title":"Int J Qualitative Methods"},{"key":"zoi241347r25","first-page":"120","article-title":"Teaching thematic analysis: overcoming challenges and developing strategies for effective learning.","volume":"26","author":"Clarke","year":"2013","journal-title":"Psychologist"},{"issue":"5","key":"zoi241347r26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamaoncol.2021.7987","article-title":"Financial toxicity of cancer treatment.","volume":"8","author":"Hussaini","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"zoi241347r27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/jpm.2020.0699","article-title":"Financial toxicity and cancer care #409.","volume":"24","author":"Sedhom","year":"2021","journal-title":"J Palliat Med"},{"issue":"5","key":"zoi241347r28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/oncolo\/oyae016","article-title":"Consuming patients\u2019 days: time spent on ambulatory appointments by people with cancer.","volume":"29","author":"Kagalwalla","year":"2024","journal-title":"Oncologist"},{"issue":"5","key":"zoi241347r29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1200\/OP.20.00065","article-title":"Park the parking.","volume":"16","author":"Premnath","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"zoi241347r30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/OP.23.00811","article-title":"Time toxicity experienced by early-phase cancer clinical trial participants.","volume":"20","author":"Durbin","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"7","key":"zoi241347r31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1200\/OP.23.00590","article-title":"Health care contact days among older cancer survivors.","volume":"20","author":"Gupta","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"zoi241347r32","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00520-020-05763-9","article-title":"Perceptions of time spent pursuing cancer care among patients, caregivers, and oncology professionals.","volume":"29","author":"Hall","year":"2021","journal-title":"Support Care Cancer"},{"issue":"11","key":"zoi241347r33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamadermatol.2023.3179","article-title":"Changes in health care costs, survival, and time toxicity in the era of immunotherapy and targeted systemic therapy for melanoma.","volume":"159","author":"Bateni","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"1","key":"zoi241347r34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S2468-1253(23)00333-3","article-title":"Management of malignant bowel obstruction.","volume":"9","author":"Gupta","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"zoi241347r35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-024-07379-7","article-title":"Characterization of time toxicity in older patients with metastatic breast cancer.","volume":"207","author":"Atre","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"zoi241347r36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00520-024-08844-1","article-title":"Time toxicity among older patients with cancer treated with palliative systemic therapy.","volume":"32","author":"Baltussen","year":"2024","journal-title":"Support Care Cancer"},{"issue":"8","key":"zoi241347r37","doi-asserted-by":"publisher","first-page":"e1342","DOI":"10.1200\/OP.22.00051","article-title":"Finding the lowest-cost pharmacy for cancer supportive care medications: not so easy.","volume":"18","author":"Etteldorf","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"zoi241347r38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00520-022-07472-x","article-title":"The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up.","volume":"31","author":"Etteldorf","year":"2022","journal-title":"Support Care Cancer"},{"issue":"5","key":"zoi241347r39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.trecan.2023.01.006","article-title":"The unequal burden of time toxicity.","volume":"9","author":"Johnson","year":"2023","journal-title":"Trends Cancer"},{"issue":"5","key":"zoi241347r40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1475-6773.13861","article-title":"Patient administrative burden in the US health care system.","volume":"56","author":"Kyle","year":"2021","journal-title":"Health Serv Res"},{"issue":"5","key":"zoi241347r41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1200\/OP.21.00500","article-title":"Payer-imposed quantity limits for antiemetics: everybody hurts.","volume":"18","author":"Haque","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"zoi241347r42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/1475-6773.13858","article-title":"Health care administrative burdens: Centering patient experiences.","volume":"56","author":"Herd","year":"2021","journal-title":"Health Serv Res"},{"issue":"8","key":"zoi241347r43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1089\/jpm.2021.0244","article-title":"Caregiver burden #419.","volume":"24","author":"Sedhom","year":"2021","journal-title":"J Palliat Med"},{"key":"zoi241347r18","volume-title":"Qualitative Research Practice: A Guide for Social Science Students and Researchers","author":"Ritchie","year":"2014"},{"key":"zoi241347r23","volume-title":"Basics of Qualitative Research: Grounded Theory Procedures and Techniques","author":"Corbin","year":"1990"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2827164\/gupta_2024_oi_241347_1732127330.27796.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:33:55Z","timestamp":1732707235000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2827164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47649","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}